Two critical n8n flaws (CVSS 9.4, 9.5) enable RCE via expression sandbox escape and public forms, risking credential exposure.

Malware is evolving to evade sandboxes by pretending to be a real human behind the keyboard. The Picus Red Report 2026 shows 80% of top attacker techniques now focus on evasion and persistence, ...

SASKATOON, Saskatchewan, Feb. 27, 2026 (GLOBE NEWSWIRE) -- MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FSE: 89N) (“MAX Power” or the “Company”) is pleased to announce that following confirmation of ...

NEW ORLEANS – Ochsner MD Anderson Cancer Center at The Gayle and Tom Benson Cancer Center in New Orleans announces a milestone in advanced cancer treatment, as the first institution in Louisiana to ...

VivaMed BioPharma (VivaMed), a clinical-stage pharmaceutical company leveraging Artificial Intelligence (AI) to discover and advance repurposed and improved therapeutic assets, today announced a ...

Patients in East Texas now have access to a new, advanced form of heart-imaging technology that physicians say can provide clearer, more accurate evaluations of blood flow to the heart and help detect ...

Tainan, Taiwan, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Advanced Biomed Inc. (Nasdaq: ADVB) (the “Company”, “Advanced Biomed”), a biotechnology company focused on developing and commercializing innovative ...

Boston University researchers in a groundbreaking study found that those with CTE have a much higher chance of being diagnosed with dementia. The largest study of its kind from the Boston University ...

Singapore’s Defence Science and Technology Agency (DSTA) and the Republic of Korea’s Korean Register (KR) have signed a Memorandum of Understanding (MOU) to co-develop a framework to strengthen ...

Kids and families filled Empire State Plaza on today as the Capital Region’s children took over the convention center for this year’s Kids Expo.MORE:Albany PAL Albany PAL gives kids a March ...

Aviceda Therapeutics has hit a snag in its goal to deliver a new treatment for geographic atrophy (GA), an advanced form of dry age-related macular degeneration. The biotech’s lead asset, AVD-104, ...